Genemedi produces core diagnostic ingredients for test of Cardiovascular disease (hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy.?) and related syndrome. GeneMedi offers paired diagnostics grade cardiac troponin T (cTnT) antibodies (monoclonal antibody, mab) and antigens for Cardiovascular disease (hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy.?) rapid test kit of cardiac troponin T (cTnT) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Cardiovascular disease (hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy.? ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.cTnT) is a?protein?that in humans is encoded by the?TNNT2?gene.?Cardiac TnT is the?tropomyosin-binding subunit of the?troponin?complex, which is located on the thin filament of striated muscles and regulates muscle contraction in response to alterations in intracellular calcium ion concentration.As part of the Troponin complex, the function of cTnT is to regulate muscle contraction. The N-terminal region of TnT that strongly binds actin most likely moves with Tm and actin during strong myosin crossbridge binding and force generation. This region is likely involved in the transduction of cooperativity down the thin filament.[14] The C-terminal region of TnT constitutes part of the globular troponin complex domain, and participates in employing the calcium sensitivity of strong myosin crossbridge binding to the thin filament.[15]Mutations in this gene have been associated with familial hypertrophic cardiomyopathy as well as with restrictive[16] and dilated cardiomyopathy. Transcripts for this gene undergo alternative splicing that results in many tissue-specific isoforms, however, the full-length nature of some of these variants has not yet been determined.[17] Mutations of this gene may be associated with mild or absent hypertrophy and predominant restrictive disease, with a high risk of sudden cardiac death.[16] Advancement to dilated cardiomyopathy may be more rapid in patients with TNNT2 mutations than in those with myosin heavy chain mutations.